Chinese regulators have greenlit the first wave of Nvidia's advanced H200 AI chip orders for major firms including Alibaba and ByteDance, marking a potential turning point for the chipmaker's access to a critical market and fueling optimism for its stock trajectory.
Disney executives detailed a robust start to fiscal 2026, driven by record-breaking animated films, a return to streaming profitability, and major investments in theme parks and AI-powered content. The company signals confidence across its interconnected portfolio.
NAPCO Security Technologies (NSSC) reported strong fiscal second-quarter results, with record revenue and expanding profitability. The company highlighted the sustained momentum of its high-margin recurring service model and announced a dividend increase.
Scotland's celebrated whisky tourism sector is showing signs of strain, with major players closing visitor centres and cutting hours amid staffing challenges and shifting demand, even as new investments open their doors.
As the United States approaches its 250th anniversary, USA TODAY examines the enduring legacy of the companies that shaped the nation's culture, economy, and global identity.
A notable investment fund has significantly reduced its position in Sirius XM Holdings, reflecting growing concerns over the audio giant's growth trajectory and competitive challenges, even as the company maintains strong cash generation.
ARK Invest's Cathie Wood has made a significant $10 million purchase of Joby Aviation shares, signaling continued conviction in the eVTOL pioneer despite recent stock volatility and a critical year ahead for FAA certification and commercialization.
NXP Semiconductors (NXPI) reports Q4 2025 earnings after the bell today. With Wall Street eyeing modest growth, the chipmaker's performance in its core automotive segment—nearly 60% of revenue—will be the key test for its 2026 trajectory.
New research reveals a stark disconnect: while a majority of firms are ramping up investment in incentive pay to fuel growth, widespread execution errors are rendering these costly programs ineffective, leaving potential revenue on the table.
Investment firm CapWealth Advisors has significantly increased its stake in telecom provider Lumen Technologies, signaling confidence amid the company's strategic pivot towards enterprise and AI infrastructure.
Investment firm Artemis Investment Management has established a significant new position in Commercial Metals Company, a leading steel producer and recycler, signaling confidence in the firm's strategic direction and growth prospects despite a recent share price surge.
Fosun International's stock has tumbled over 14% in the last 90 days, reigniting the debate over the Chinese conglomerate's true worth. With shares trading at HK$4.12 against a widely cited fair value of HK$5.77, analysts are divided on whether this is a moment of market overreaction or a sign of deeper structural challenges.
With Devon Energy's merger with Coterra Energy set to create a shale powerhouse, CEO Clay Gaspar will lead the transition, relocating the corporate headquarters from Oklahoma City to Houston while maintaining a significant operational foothold in Oklahoma.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
Regulators closed Chicago's Metropolitan Capital Bank & Trust on Friday, marking the first U.S. bank failure this year. The FDIC facilitated a swift sale of most assets and deposits to Detroit's First Independence Bank, ensuring no depositor losses.
Restaurant Brands International (RBI) has formed a joint venture with private equity firm CPE, ceding majority control of Burger King's China operations in a deal aimed at turbocharging growth. The partnership targets a more than tripling of restaurants to over 4,000 by 2035, leveraging local expertise and capital.
A significant reset in CareCloud's (CCLD) price target by analysts is prompting a fresh look at the healthcare IT firm's risk-reward profile. This shift reflects evolving perspectives on the company's trajectory and market position. We examine the catalysts for this change and its implications for investors.
Fundstrat's Tom Lee suggests the brutal crypto sell-off may be nearing its end, even as his firm Bitmine faces staggering paper losses on its massive Ethereum bet. The call comes amid a wider debate on the health of digital asset treasuries.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
Regular savings accounts offer attractive rates for disciplined savers, but come with strict rules on monthly deposits and withdrawals. Our guide breaks down the latest deals and what you need to know before committing your cash.
